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6,204.77.Number of employees who had an inpatient visit increased from 3 to 7,
with no recurrence of pre-visit events. A decrease in total health care expenditures
by over 14%was observed. Preliminary analysis for the second objective shows that
on average employees spent $406.97/patient/year more when they dropped out of
the program than if they stayed enrolled. CONCLUSIONS: Pharmacist led MTM-
program helped reduce health care expenditure for the employer. Improving re-
tention for the program could help substantiate these cost savings.
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OBJECTIVES: To identify existing gender differences in utilization of preventive
care services in the United States (US) population using a national database. Few
studies have pointed towards role of gender in determining utilization of preven-
tive care service but the issue hasn’t been explored using a nationally representa-
tive population.METHODS:A retrospective, cross-sectional study using 2008MEPS
(Medical Expenditure Panel Survey) data, a nationally representative survey of US
population, which reports their pattern of medical care utilization. Guideline rec-
ommendations widely used in clinical practice, such as NCEP, American Dental
Society, JNC-VII etc., were used to determine appropriate utilization of preventive
care services. Descriptive statistics were used to describe the population charac-
teristics while multivariate logistic regression model was built to predict the utili-
zation of the various preventive care services (blood pressure check up, lipid
screening, dental check up, sigmoidoscopy/colonoscopy andflu vaccination), using
gender as the primary predictor variable, while controlling for age, income, race/
ethnicity etc. RESULTS:Out of 33,066 respondents, 20,336met the inclusion criteria
for blood pressure check up, 23,058 met the inclusion criteria for dental check up,
19,543 met the inclusion criteria for flu vaccinations, 2,986 met the inclusion crite-
ria for lipid screening, and 4,195 met the inclusion criteria for sigmoidoscopy/
colonoscopy screenings. Gender was found to predict utilization of preventive care
services.Maleswere found less likely to utilize blood pressure check up (OR 0.327,
CI 0.2970.359), lipid screening (OR 0.768, CI0.694- 0.85), dental check up (OR
0.634,CI  0.599-0.671), and flu vaccination (OR  0.680, CI 0.637- 0.726). In case of
sigmoidoscopy and colonoscopy screenings, the disparities were not significant,
though utilization was still found to be higher in females. CONCLUSIONS: The study
helped determine gender disparities in utilizing preventive care services in US
population. Utilization of preventive care services needs to be encouraged inmales.
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OBJECTIVES: Limited data exist regarding the economic burden of complications
arising during stroke-related hospitalizations. This study sought to document the
rate of complications arising during hospitalization (i.e., defined as diagnoses re-
corded upon discharge but not observed at admission) for hemorrhagic (HS) or
ischemic stroke (IS), and describe characteristics of complicated hospitalizations.
METHODS: Data for hospitalizations with a primary diagnosis of HS (ICD-9-CM
codes 430.xx, 431.xx, or 432.xx) or IS (433.x1, 434.xx, or 436.xx) in the 2008 HCUP
Michigan State Inpatient Database were analyzed. Incidence of complications de-
veloped during hospitalization among patientswith a primary diagnosis of HS or IS
were assessed, and resource-based outcomes (e.g., total cost, length of stay [LOS])
among, and other characteristics of, stays with complications, compared to un-
complicated hospitalizations, analyzed. RESULTS: Of the 1.3 million hospitaliza-
tions occurring in Michigan in 2008, 19,065 had a primary diagnosis of HS or IS.
Among these, 20.6% (n3,922) had evidence of1 complications arising during the
stay. No differences in patient age (mean: 70.4 versus 70.7 years; p0.3293) or
gender distribution (53% versus 54% female; p0.3476) between complicated and
uncomplicated hospitalizations were observed. The top-5 most frequently ob-
served complications were urinary tract infection, site not specified; hypopotasse-
mia; acute respiratory failure; pneumonitis due to inhalation of food or vomitus;
and acute kidney failure, unspecified. Compared to uncomplicated hospitaliza-
tions, mean LOS and total costs for complicated stays were significantly greater:
10.5 versus 4.5 days (p0.0001) and $28,608 versus $10,747 (p0.0001), respectively.
Patients with 1 complications spent 2.8 (SD6.4) days in an ICU, and a greater
proportion with complications than without died during hospitalization (11.4%
versus 6.6%; p0.0001). CONCLUSIONS: The cost of stroke-related hospitalizations
with complications is significant,3 times greater than stroke-related hospitaliza-
tions without complications. Efforts to improve inpatient stroke management
strategies may help lower the incidence of complications, reduce associated costs,
and improve patient outcomes.
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OBJECTIVES: The patient-centered medical home has been touted as a way to
improve patient care and reduce overall healthcare costs. Pharmacists are qualified
to provide many of the services that are core to the medical home concept as part
of the physician-directed team; however, the pharmacist’s role in the medical
home has received little attention. METHODS: Medical record review was per-
formed on all patients referred to the pharmacist from 7/1/2009 to 12/1/2010within
a community-based, medical home, primary care practice. Patients referred in-
cluded those non-compliant to prior physician recommendations for lifestyle
modifications and/or those not achieving therapeutic goals. Pharmacist interven-
tions included disease state education, therapeutic lifestylemodification andmed-
ication counseling, and recommendations for therapy optimization. Primary anal-
yses examined pre/post changes in the subset of patients with diabetes. Outcomes
assessed were changes in hemoglobin A1c (HbA1c), lipid fractions, body mass in-
dex (BMI), weight, and goal attainment for HbA1c and low-density lipoprotein cho-
lesterol (LDL-C), utilizing paired t-tests, Wilcoxon signed-rank and McNemar’s
tests as appropriate. RESULTS: One hundred-seven patients were referred to the
pharmacist, 49 with diabetes. Diabetes patients had amean age of 579 years; 53%
weremale. HbA1c values decreased from 8.7% to 7.4% (	1.3%; 95% CI0.5% to
2.1%; p0.003). The percentage of patients achieving HbA1c levels below 8% rose
from 50% to 75% (p0.021) and below 7% rose from 28% to 47%, although this was
not statistically significant (p0.109). Statistically significant decreases were ob-
served in diastolic blood pressure, LDL-C, total cholesterol, triglycerides, BMI and
weight. The percentage of patients achieving LDL-C levels 100mg/dL increased
from 30% to 74% (p0.002). CONCLUSIONS: Pharmacist involvement in this com-
munity basedmedical homewas associatedwith positive improvements in clinical
markers for these diabetic patients. These pilot study results support the inclusion
of pharmacists as healthcare team members in future medical home demonstra-
tion projects.
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OBJECTIVES: To compare side effect data reported from members of a patient-
registry to information contained in the product labeling of four different choles-
terol medications each representing a different therapeutic class. METHODS: A
random sample of U.S. MediGuard.org members who reported taking niacin (Nias-
pan), fenofibrate (Tricor), simvastatin (Zocor), or colesevelam (Welchol), were in-
vited to complete a validated online treatment satisfaction survey that includes
questions related to side effects. MediGuard.org is a free medication monitoring
service that provides information to over 2.5 million members in the US, UK,
France, Germany, Spain, and Australia. A comparison list of adverse effects and
frequencies reported during clinical trials was extracted from the branded package
insert for each medication. RESULTS: Feedback was obtained from 56 colesvelam,
108 niacin, 216 fenofibrate, and 660 simvastatin patients. Niacin patients had the
highest prevalence of side effects (62%), primarily flushing (55%) and pruritis (14%).
23% of colesevelam members reported side effects: the most common were con-
stipation (14%) and bloating/gas (2%). For patients treated with fenofibrate, 16%
reported side effects withmyalgia (4.2%) and arthralgia (1.4%) being themost com-
mon. Similar to fenofibrate, 16% of simvastatin patients reported side effects and
again, myalgia (6.2%) and fatigue (2.1%) had the most mentions. Finally, 2% of
niacin, 22% of fenofibrate, 29% of simvastatin, and 36% of colesevelam patient
reports included side effects not included in the product labeling. CONCLUSIONS:
On-line patient communities are an emerging resource for confirming adverse
events reported during clinical trials and for capturing previously undocumented
signals. In tandem to the current post-marketing spontaneous adverse event re-
porting system, longitudinal patient registries can provide insight not only on the
number of adverse events, but also a prevalence rate of those who experience
versus those who do not experience side effects.
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OBJECTIVES: The objectives of this audit are: (1) to determine the percentage of
patients who are discharged on secondary prevention medication following acute
myocardial infarction (AMI) including: aspirin, clopidogrel, ACE inhibitors (ACEi),
-blockers (BB), and statins; (2) to identify what dose each patient is discharged on
regarding ACEi and BB and when they are initiated; (3) to explore the relationship
between blood pressure and ACEi dose titration; (4) to explore the relationship
between heart rate and BB dose titration.METHODS: A prospective audit was car-
ried out at the London Chest Hospital (LCH) from June 15-June 28, 2009. All patients
who were admitted to the coronary care unit (CCU) with a final diagnosis of AMI
were included. Patients were excluded if they died prior to hospital discharge.
Patients’ demographics, vital signs, drug history, past medical history, drugs dur-
ing hospital stay and at discharge were collected. RESULTS: 33 patients were in-
cluded in this audit (mean age 59.7  12.7 years, 79% males, 21% females) with an
average length of stay of 2.2 days. 88% of the patients were started ACEi and BB on
day 2 of hospitalization. For patients receiving ACEi and BB only 41% were titrated
towards the optimal dose. 78% of the opportunities to titrate ACEi according to
blood pressure and 55% of the opportunities to titrate BB according to heart rate
were not taken. At discharge, 100% were prescribed aspirin, statins, and BB; while
97% were prescribed ACEi and clopidogrel. CONCLUSIONS: This audit reveals high
use of secondary prevention medication at the LCH following AMI. Although there
are opportunities for further dose titration prior to discharge, further work is re-
quired to establish reasons for missing these opportunities.
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